1-55063514-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_174936.4(PCSK9):​c.2009G>A​(p.Gly670Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.954 in 1,613,984 control chromosomes in the GnomAD database, including 735,949 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.90 ( 62321 hom., cov: 35)
Exomes 𝑓: 0.96 ( 673628 hom. )

Consequence

PCSK9
NM_174936.4 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:21

Conservation

PhyloP100: 0.938

Publications

187 publications found
Variant links:
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.2124301E-6).
BP6
Variant 1-55063514-G-A is Benign according to our data. Variant chr1-55063514-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 36670.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.955 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_174936.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
NM_174936.4
MANE Select
c.2009G>Ap.Gly670Glu
missense
Exon 12 of 12NP_777596.2
PCSK9
NM_001407240.1
c.2132G>Ap.Gly711Glu
missense
Exon 13 of 13NP_001394169.1A0AAQ5BGX4
PCSK9
NM_001407241.1
c.2051G>Ap.Gly684Glu
missense
Exon 12 of 12NP_001394170.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PCSK9
ENST00000302118.5
TSL:1 MANE Select
c.2009G>Ap.Gly670Glu
missense
Exon 12 of 12ENSP00000303208.5Q8NBP7-1
PCSK9
ENST00000710286.1
c.2366G>Ap.Gly789Glu
missense
Exon 12 of 12ENSP00000518176.1A0AA34QVH0
PCSK9
ENST00000713786.1
c.2132G>Ap.Gly711Glu
missense
Exon 13 of 13ENSP00000519088.1A0AAQ5BGX4

Frequencies

GnomAD3 genomes
AF:
0.900
AC:
136902
AN:
152176
Hom.:
62302
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.743
Gnomad AMI
AF:
0.950
Gnomad AMR
AF:
0.957
Gnomad ASJ
AF:
0.946
Gnomad EAS
AF:
0.948
Gnomad SAS
AF:
0.977
Gnomad FIN
AF:
0.946
Gnomad MID
AF:
0.937
Gnomad NFE
AF:
0.961
Gnomad OTH
AF:
0.928
GnomAD2 exomes
AF:
0.948
AC:
237334
AN:
250432
AF XY:
0.952
show subpopulations
Gnomad AFR exome
AF:
0.737
Gnomad AMR exome
AF:
0.973
Gnomad ASJ exome
AF:
0.946
Gnomad EAS exome
AF:
0.948
Gnomad FIN exome
AF:
0.947
Gnomad NFE exome
AF:
0.962
Gnomad OTH exome
AF:
0.957
GnomAD4 exome
AF:
0.959
AC:
1402225
AN:
1461688
Hom.:
673628
Cov.:
91
AF XY:
0.960
AC XY:
698317
AN XY:
727154
show subpopulations
African (AFR)
AF:
0.727
AC:
24343
AN:
33478
American (AMR)
AF:
0.970
AC:
43386
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.949
AC:
24786
AN:
26130
East Asian (EAS)
AF:
0.951
AC:
37739
AN:
39700
South Asian (SAS)
AF:
0.976
AC:
84218
AN:
86248
European-Finnish (FIN)
AF:
0.949
AC:
50632
AN:
53342
Middle Eastern (MID)
AF:
0.954
AC:
5441
AN:
5706
European-Non Finnish (NFE)
AF:
0.966
AC:
1074311
AN:
1111982
Other (OTH)
AF:
0.950
AC:
57369
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
3731
7462
11192
14923
18654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21624
43248
64872
86496
108120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.899
AC:
136972
AN:
152296
Hom.:
62321
Cov.:
35
AF XY:
0.901
AC XY:
67124
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.743
AC:
30858
AN:
41546
American (AMR)
AF:
0.958
AC:
14662
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.946
AC:
3286
AN:
3472
East Asian (EAS)
AF:
0.949
AC:
4907
AN:
5172
South Asian (SAS)
AF:
0.977
AC:
4723
AN:
4834
European-Finnish (FIN)
AF:
0.946
AC:
10050
AN:
10624
Middle Eastern (MID)
AF:
0.935
AC:
275
AN:
294
European-Non Finnish (NFE)
AF:
0.961
AC:
65379
AN:
68014
Other (OTH)
AF:
0.929
AC:
1966
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
664
1328
1993
2657
3321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.945
Hom.:
238122
Bravo
AF:
0.893
TwinsUK
AF:
0.968
AC:
3589
ALSPAC
AF:
0.967
AC:
3727
ESP6500AA
AF:
0.743
AC:
3272
ESP6500EA
AF:
0.965
AC:
8296
ExAC
AF:
0.943
AC:
114445
Asia WGS
AF:
0.951
AC:
3306
AN:
3478
EpiCase
AF:
0.964
EpiControl
AF:
0.966

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
Hypercholesterolemia, familial, 1 (6)
-
-
5
Hypercholesterolemia, autosomal dominant, 3 (5)
-
-
4
not specified (4)
-
-
2
Familial hypercholesterolemia (2)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypobetalipoproteinemia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.86
DANN
Benign
0.59
DEOGEN2
Benign
0.052
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.25
T
MetaRNN
Benign
0.0000012
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-2.3
N
PhyloP100
0.94
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.52
N
REVEL
Benign
0.067
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.052
MPC
0.29
ClinPred
0.0048
T
GERP RS
0.35
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.060
gMVP
0.27
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs505151; hg19: chr1-55529187; COSMIC: COSV107314306; COSMIC: COSV107314306; API